Opinion: Taxpayers Should Cover Portion of Patent Costs

Federal grant support for technology transfer at universities will strengthen the national innovation system.

Written byPaul R. Sanberg
| 4 min read
technology transfer patent licensing academic research federal grant patent innovation

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

ABOVE: © ISTOCK.COM, PESHKOV

The Bayh-Dole Act was a watershed event in American higher education and innovation. The legislation, enacted almost 40 years ago, gave universities, faculty members, and student inventors the rights to patent discoveries and unleashed an era of inventive collaboration that has helped shape American competitiveness globally. But amid the resounding success of the Act remains a difficult truth for innovative and entrepreneurial universities: Only a handful of highly successful institutions with blockbuster portfolios generate enough licensing income to support the cost of university technology transfer. For everyone else the process is a wash or even a loss.

In recognition that most universities need financial support for the costly process of patenting new inventions emerging from federally funded research, the National Institute of Standards’s Return on Investment Initiative Final Green Paper that was published in April 2019 recommends allocating a small portion of federal grant support to ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies